News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Daily News HFSA 2021 In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity Michael O'Riordan September 15, 2021
News Conference News HFSA 2021 PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF Todd Neale September 13, 2021
News Conference News EuroPCR 2021 Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances Caitlin E. Cox May 21, 2021
News Conference News ACC 2021 REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay Caitlin E. Cox May 16, 2021
News Conference News ACC 2021 ‘Enormous’ QoL Improvements With Mavacamten in HCM Shelley Wood May 15, 2021
News Daily News Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF L.A. McKeown March 25, 2021
News Daily News Beyond Research, KCCQ Scores Can Help Predict Events Post-TAVI/TMVR Yael L. Maxwell February 25, 2021